The CGIX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CGIX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CGIX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CGIX Detailed Price Forecast - CNN Money||View CGIX Detailed Summary - Google Finance|
|View CGIX Detailed Summary - Yahoo! Finance||View CGIX Stock Research & Analysis - Zacks.com|
|View CGIX Trends & Analysis - Trade-Ideas||View CGIX Major Holders - Barrons|
|View CGIX Call Transcripts - NASDAQ||View CGIX Breaking News & Analysis - Seeking Alpha|
|View CGIX Annual Report - CompanySpotlight.com||View CGIX OTC Short Report - OTCShortReport.com|
|View CGIX Fundamentals - TradeKing||View CGIX SEC Filings - Bar Chart|
|View Historical Prices for CGIX - The WSJ||View Performance/Total Return for CGIX - Morningstar|
|View the Analyst Estimates for CGIX - MarketWatch||View the Earnings History for CGIX - CNBC|
|View the CGIX Earnings - StockMarketWatch||View CGIX Buy or Sell Recommendations - MacroAxis|
|View the CGIX Bullish Patterns - American Bulls||View CGIX Short Pain Metrics - ShortPainBot.com|
|View CGIX Stock Mentions - StockTwits||View CGIX Stock Mentions - PennyStockTweets|
|View CGIX Stock Mentions - Twitter||View CGIX Investment Forum News - Investor Hub|
|View CGIX Stock Mentions - Yahoo! Message Board||View CGIX Stock Mentions - Seeking Alpha|
|View Insider Transactions for CGIX - SECform4.com||View Insider Transactions for CGIX - Insider Cow|
|View CGIX Major Holdings Summary - CNBC||View Insider Disclosure for CGIX - OTC Markets|
|View Insider Transactions for CGIX - Yahoo! Finance||View Institutional Holdings for CGIX - NASDAQ|
|View CGIX Stock Insight & Charts - FinViz.com||View CGIX Investment Charts - StockCharts.com|
|View CGIX Stock Overview & Charts - BarChart||View CGIX User Generated Charts - Trading View|
Edited Transcript of CGIX earnings conference call or presentation 15-May-18 12:30pm GMT
Posted on Tuesday June 19, 2018
Q1 2018 Cancer Genetics Inc Earnings Call
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
Posted on Tuesday June 12, 2018
Cancer Genetics, Inc. (CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced the appointment Michael McCartney as the Company’s Chief Commercial Officer, effective immediately. Mr. McCartney will be responsible for developing and overseeing Cancer Genetics’ commercial strategy and spearheading the Company’s business development initiatives.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the June 4, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Cancer Genetics, Inc. (“Cancer Genetics” or the “Company”) (NASDAQ: CGIX) securities between March 23, 2017, and April 2, 2018, inclusive (the “Class Period”). To obtain information or actively participate in the class action, please visit the Cancer Genetics page on our website at www.glancylaw.com/case/cancer-genetics-inc. Investors suffering losses on their Cancer Genetics investments are encouraged to contact Lesley Portnoy of GPM to discuss their legal rights in this class action at 310-201-9150 or by email to firstname.lastname@example.org.
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Posted on Monday June 04, 2018
LOS ANGELES, CA / ACCESSWIRE / June 4, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cancer Genetics, Inc. ("Cancer Genetics" or ''the Company'') (NASDAQ: CGIX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 23, 2017 and April 2, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before June 4, 2018.